Smital Shah

Smital Shah

Director of Finance/CFO at LYELL IMMUNOPHARMA, INC.
49 year
Health Technology
Consumer Services

Profile

Smital Shah is Chief Financial & Business Officer at Lyell Immunopharma, Inc. since 2026.
Former roles include Independent Director at Graphite Bio, Inc., Independent Director at Pliant Therapeutics, Inc. from 2019 to 2025, Treasurer at Gilead Sciences, Inc. from 2012 to 2014, and Chief Financial & Business Officer at ProQR Therapeutics NV from 2018 to 2022.
Education includes graduate studies at Virginia Polytechnic Institute & State University, undergraduate studies at the University of Mumbai, and an MBA from Haas School of Business.

Smital Shah active positions

CompaniesPositionStart
LYELL IMMUNOPHARMA, INC. Director of Finance/CFO 2026-03-08

Former positions of Smital Shah

CompaniesPositionEnd
PLIANT THERAPEUTICS, INC. Director/Board Member 2025-06-04
PROQR THERAPEUTICS N.V. Director of Finance/CFO 2022-09-30
GILEAD SCIENCES, INC. Treasurer 2014-08-31
LENZ THERAPEUTICS, INC. Director/Board Member -
See the detail of Smital Shah's experience

Training of Smital Shah

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

24

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology